About the Journal of Hospital Medicine
The Journal of Hospital Medicine (JHM) is the premier peer-reviewed publication for the specialty of Hospital Medicine, and is dedicated to publishing evidence that will transform care of the hospitalized patient.
JHM advances excellence in Hospital Medicine clinical care and research through the dissemination of peer-reviewed studies, evidence-based clinical care updates and reviews, and rigorous evaluations of approaches to improve the quality, safety, and value of care for hospitalized adults and children.
JHM’s Editorial Priorities
JHM is a peer-reviewed publication of the Society of Hospital Medicine and is published 12 times per year. JHM publishes manuscripts that address the care of hospitalized adults or children.
Broad areas of interest include 1) Treatments for common inpatient conditions (such as pneumonia, COPD, sepsis, thromboembolism, or asthma); 2) Approaches to improving perioperative care; 3) Improving care for hospitalized patients with geriatric or pediatric vulnerabilities (such as mobility problems, or those with complex longitudinal care); 4) Evaluation of innovative health delivery system or educational models; 5) Approaches to improving the quality, safety, and value of healthcare across the acute and post-acute continuum of care; and 6) Evaluation of policy and payment changes that affect hospital and post-acute care.
Papers with the highest likelihood of publication use robust research methods to examine questions of importance to the field of adult or pediatric Hospital Medicine, and produce results that will influence clinical practice or healthcare policy.
Journal of Hospital Medicine Article Types
JHM publishes articles in the following categories:
1) Research Articles:
a. Original Research (Full length)
b. Brief Reports
3) Clinical Care Conundrums*
4) Perspectives in Hospital Medicine
5) Choosing Wisely®: Next Steps in Improving Healthcare Value*
6) Choosing Wisely®: Things We Do For No Reason*
8) Letters to the Editor
*Require approval by JHM Editorial staff
Note: Word count limits include the abstract through conclusion (does not include references).
- Original Research (2,750 words not including abstract or references, structured 250-word abstract, no more than 4 tables or figures, no more than 40 references): Full length Original Research papers report results of randomized controlled trials, evaluation of diagnostic tests, prospective cohort studies, case controlled studies, or high quality observational or qualitative studies. Please refer to Author Guidelines for best practices in presenting results from specific types of research.
- Brief Reports (1,500 words, unstructured 150-word abstract, no more than 2 tables or figures, no more than 15 references): Brief reports provide focused reporting of Original Research findings. Though shortened in format, they should attempt to adhere to JHM Author Guidelines for reporting specific types of research.
Review papers (word limit 2750, unstructured 250-word abstract, 4 or fewer tables or figures, 50 or fewer references) should address JHM priority areas and provide an evidence synthesis that describes how the practice should affect hospitalists’ practice or future research. JHM strongly prefers systematic reviews to narrative reviews, with further emphasis on reviews that answer a specific clinical question about diagnostic, prognostic, or therapeutic clinical practices.
Clinical Care Conundrums*
The Clinical Care Conundrums (CCC) series (2,750 words not including references, no more than 4 tables or figures, no more than 20 references) are narrative, clinical problem-solving exercises that are developed in a collaborative fashion between the submitting author and JHM Editors and/or National Correspondents.
Note: JHM does not accept case reports or case series.
CCCs include a challenging diagnostic or therapeutic dilemma synthesized by an expert clinician who is not otherwise familiar with the case. Appropriate CCCs are enigmatic in their presentation, provide multiple opportunities for clinical education, and have a diagnosis relevant to the Journal’s readership.
Submissions to this section require pre-approval by the editorial staff. Authors interested in submitting a CCC should review the previously published JHM CCC, "The third time's the charm," and consider whether their case can meet this required format. Prior to preparing a manuscript, prospective authors must read the attached letter and email a prospectus to the managing editor for pre-submission review.
If the prospectus is of interest to JHM, the author will then be invited to submit a draft CCC for formal review and further development by Editors or JHM National Correspondents. Initiation of this collaborative review and revision process does not guarantee acceptance.
Perspectives in Hospital Medicine
Perspectives in Hospital Medicine (1,500 or fewer words, no more than 1 table or figure, no more than 20 references) articles point out new breakthroughs in clinical therapies, controversies in care delivery innovation or policy, or factors that will shape the future of Hospital Medicine.
Choosing Wisely®: Next Steps in Improving Healthcare Value
Choosing Wisely®: Next Steps in Improving Healthcare Value articles (1500 words, unstructured 150-word abstract, 1 table, 15 references) are perspective pieces describing healthcare value initiatives relating to or impacting the practice of hospital medicine.
Areas of interest include scholarly reviews or methodologic/policy evaluations of new value-focused innovations, and proposals for new models of care intended to improve healthcare value at the health system or delivery organization level. Manuscripts highlighting potential roles for hospital-based physicians in new models and those incorporating ideas from outside healthcare are particularly valued.
In general, manuscripts pertaining to more focused value initiatives (e.g., quality improvement projects carried out in selected units or at a single hospital) are better suited for other Journal of Hospital Medicine article formats.
Submissions to this section require pre-approval by the editorial staff. Interested authors should submit a brief (500 word) description of the proposed topic to email@example.com.
Manuscripts potentially relevant to this topic area will be assigned to this section at the discretion of the Editors.
Choosing Wisely®: Things We Do For No Reason
Choosing Wisely®: Things We Do For No Reason (1500 words, unstructured 150-word abstract, 1 table, 15 references) are articles that, using a case-based approach, describe practices (tests, procedures, management strategies) that may be poorly supported by evidence or which have become part of standard practice based despite the availability of less expensive or higher value alternatives.
Submissions to this section require pre-approval by the editorial staff. Interested authors should submit a brief (500 word) description of the proposed topic to the JHM managing editor for consideration before submission.
Letters to Editor
Letters to the Editor (200 words, no abstract, no tables or figures, fewer than 5 references) provide comments on papers published in JHM, responses from authors, and occasional Corrections by authors.
Editorials are typically invited by the Editor and provide additional context or interpretation of research published in a specific issue.
Description of the JHM Review Process
Manuscripts are accepted for review with the understanding that the same work has not been previously published, that it is not under consideration for publication elsewhere, and that its submission for publication has been approved by all persons listed as authors and by the appropriate authority at the institution where the work was carried out.
Manuscripts undergo initial review by JHM Editors at which time a decision whether to request peer review is made, usually within 7 business days.
If sent for peer review, estimates for the remainder of the JHM review process are provided below.
|# of Days to First Decision||# of Days to Final Decisiona|
aDoes not include time in revision with author. Peer reviewer identities are kept confidential, but author identities are made known to reviewers. Authors can check the status of their manuscript by accessing their password-protected manuscript file at https://mc.manuscriptcentral.com/JHM. Or, please contact the Editorial Office by e-mail at firstname.lastname@example.org.
If a revision is requested, authors will have up to 90 days in which to submit their revised manuscript. Extensions will be considered on a case-by-case basis.
At the time of acceptance, Authors will also be asked to generate two tweets to accompany their paper’s publication via the JHM Twitter feed.
The Publisher will send electronic proofs to the corresponding author for correction. Please check them carefully as it is the author’s responsibility to ensure that there are no errors in the proofs. Changes done in the course of copyediting to conform to Journal style should be allowed to stand if they do not alter meaning. All changes should be clearly marked and the proofs promptly returned to the Publisher as directed.
Authors will receive a reprint order form and a price list with the page proofs. Reprint requests should be returned with the corrected proofs, if possible.
Attention: Please note manuscript submissions to JHM now submitted for plagiarism detection through CrossCheck. CrossCheck is a multi-publisher initiative to screen published and submitted content for originality, and uses iThenticate software to detect instances of overlapping and similar text in submitted manuscripts. To find out more about CrossCheck visit crossref.org/crosscheck.html. Authors are also encouraged to review the Office of Research Integrity's definition of self-plagiarism, which can be found at ori.hhs.gov/plagiarism-13.
Manuscript Submission Requirements
The Journal of Hospital Medicine is pleased to offer web-based submissions and peer-review. To submit your manuscript online, go to http://mc.manuscriptcentral.com/JHM.
- Prepare your manuscript and illustrations in the appropriate format, according to the instructions given below. Please also be sure that your paper conforms to the scientific and style instructions of the journal.
- If you are submitting for the first time, you will need to create a new account. You can create one for yourself in the system at the submission site by clicking on the “Create Account” button.
- If you are unsure of your password, enter your e-mail address in the “Password Help” box. If you have an account, a temporary password will be e-mailed to you to gain access to your account. Subsequently, to monitor the progress of your manuscript throughout the review process, log in to ScholarOne Manuscripts periodically and check your Author Center.
- When you are ready to submit your manuscript, let the system guide you through the submission process. Online help is available to you at all times during the process by clicking "Get Help Now" in the upper right hand corner of the screen. You are also able to exit and re-enter the submission process at any stage by clicking on “Unsubmitted Manuscripts” in your Author Center and revising your information. When all steps in the submission process are complete, click the “Submit” button located at the bottom right hand corner of the submission screen’s last page. At the end of a successful submission, a confirmation screen with a manuscript number will appear and you will receive an e-mail confirming that the manuscript has been received by the journal. If this does not happen, please check your submission and/or contact tech support at email@example.com .
- All submissions are kept strictly confidential.
Manuscript Format Guidelines
Please follow all formatting instructions detailed below. Manuscripts that do not adhere to the guidelines below may be returned to authors for correction.
Please upload all manuscripts as Word files (.doc or .docx) using the “Main Document” file designation in ScholarOne. Tables and Digital Images should be uploaded separately as described below. Do not include tables or images within the main document.
Cover Letter: A cover letter must be uploaded to ScholarOne Manuscripts upon submission.
Keywords: The author should provide keywords to appear after the abstract and to be used for the subject index at the end of the volume.
Title Page: All documents must include a title page listing article title; running title (a short version of the title, up to 40 characters); all authors with academic degrees and affiliations; and complete mailing address, telephone and fax numbers and email address for corresponding author.
All relevant financial conflicts of interest should appear on the title page, and can be transcribed from the ICMJE COI form.
Abstracts: Abstracts should accompany all submissions except Editorials, Clinical Care Conundrums, and Letters.
Unstructured abstracts should be no longer than 150 words, and describe the intent of the manuscript, its approach or rationale, and major findings (or key points for readers) in a paragraph format.
|Original Research||Systematic Reviews and Meta-analyses||Reviews||Brief Report, Choosing Wisely articles types|
|Abstract type||Structured (250 words)||Structured (250 words)||Unstructured (250 words)||Unstructured (150 words)|
|Components||Background, Objective, Design, Setting, Patients, Intervention, Measurements, Results, and Conclusions||Background, Purpose, Data Sources, Study Selection, Data Extraction, Data Synthesis, Conclusions.||Background, Methods, Results and Conclusion(s)||Intent of project/manuscript, the approach taken, and major findings, described in 150 word paragraph|
Manuscripts should normally be divided into four sections as follows:
- Introduction: The purpose of the study should be described with some background. Citations should be confined to work that is directly relevant and bulk citations should be avoided. If the work is hypothesis-driven, authors are encouraged to include the hypothesis in this section.
- Methods (or Patients and Methods): Describe the study design (e.g., prospective or retrospective, randomized or observational, inclusion and exclusion criteria, duration of study), setting, and the study population (demographics, length of follow-up). Any interventions should be described in detail and how they were implemented. Please provide flowcharts if possible to clarify patient enrollment and loss to follow-up.
- Results: Provide a detailed report on the data obtained during the study. All data in the text must be consistent throughout the manuscript, including any illustrations, legends, or tables.
- Conclusion/Discussion: The Discussion should summarize but not repeat the Results. Be succinct. Is your hypothesis affirmed or refuted? Analyze your data and discuss strengths and limitations of the study. Consider structuring the discussion of research reports and systematic reviews, including meta-analyses, in the following sequence. First, briefly summarize key findings, with particular emphasis on how the findings add to the body of pertinent knowledge. Second, discuss possible mechanisms and explanations for the findings. Third, compare study results with relevant findings from other published work. Fourth, discuss the limitations of the present study and any methods used to minimize or compensate for those limitations. Fifth, mention any crucial future research directions. Sixth, conclude with a brief section that summarizes in a straightforward and circumspect manner the clinical implications of the work.
All tables should be uploaded separately as Word files (.doc or .docx) using the file designation “Table”. There is a 4 table/figure limit for all Original Research and Review articles.
- Please ensure that tables do not exceed one typewritten page, single spaced. Large tables are difficult and expensive to typeset and can be avoided by reformatting some information as supplementary material. JHM does not publish multipart tables (Table 1A and 1B, etc.).
- Do not use color or shading within tables.
- Tables should be numbered consecutively with Arabic numerals in the order of their appearance in the text. Tables should be single-spaced (horizontal lines are used only to separate headings; vertical rules are not used).
- Data appearing in tables should be summarized, not duplicated, in the text. All data cited in the text should be checked carefully against the corresponding data in the tables to ensure that they correspond.
- Provide a concise title that describes each table. Abbreviations used in the table must be defined in a footnote to the table.
Figures, Charts, Images
All digital art (this includes Figures, Schemes, Charts, etc) must be saved as TIFF or EPS files using the file designation “Image” UNLESS it is line art which may be submitted as Word documents using the file designation “Image”. Submission in application file formats or submission as any format other than TIFF or EPS is not recommended. Submission of JPEG, PDF, Excel, PPT, and BMP files will result in the article being unsubmitted. Images should be flattened prior to submission, i.e. files should not contain layers. Please save all images separately and supply numbered headings and captions for each within the manuscript Word file and in the manuscript details. There is a 4 table/figure limit for all Original Research and 3 table/figure limit for all Review articles. Further instructions:
- Image resolution: All images must have a resolution yielding 300 dpi or higher. To ensure that your digital graphics are suitable for print purposes please go to Rapid Inspector at: http://rapidinspector.cadmus.com/zwi/index.jsp . This free, stand-alone software application will help you to inspect and verify illustrations right on your computer.
- Image sizing: Art should be created or scaled to the size intended for print; no enlargement or reduction should be necessary. Digital art files should be cropped to remove non-printing borders. Files should be checked carefully for any type, lines, or other elements outside the illustration that are not intended for print. Such elements should be removed before submission. Image orientation should be the same as intended for print.
- Color illustrations: Color illustrations are helpful in demonstrating findings and illustrating concepts. All color figures will be reproduced in full color in the online edition of the journal as well as in print at no cost to the authors.
- Patient identification: Patient identification must be masked in photographs; otherwise, a signed permission statement is required. A simple black box covering the eyes is not sufficient.
Acknowledge only persons who have contributed to the scientific content or provided technical support. Authors are responsible for obtaining and submitting to the editorial office written permission from anyone (with a MD or a PhD) named in the Acknowledgements section. The acknowledgement section should precede the reference list. All disclosures/ conflicts of interest should appear on the title page.
- Every effort should be made to avoid jargon, to spell out all nonstandard abbreviations the first time they are mentioned, and to present the contents of the study as clearly and concisely as possible.
- Figure legends should be typed double-spaced and numbered with Arabic numerals corresponding to the illustrations. When symbols, arrows, numbers, or letters are used to identify parts of the illustrations, each should be explained clearly in the legend. For photomicrographs, the internal scale markers should be defined and the methods of staining should be given.
- For experiments in which humans were studied, you must have approval from an Institutional Review Board (IRB), preferably at the site of the study, and describe your method of informed consent.
- Patients’ names, initials, or hospital numbers should not be used. For experiments on animals, indicate whether the institution’s or the National Research Council’s guide for the care and use of laboratory animals was followed.
- For drugs and chemicals, the generic name should be used at first mention and, preferably, thereafter. A trade name may appear in parentheses and should be capitalized.
- Statistical methods should be described in detail.
- The statement “no significant difference was found between two groups” cannot be made unless a power study was done and the value of alpha or beta is reported.
- Use of the word significant requires reporting of a p value.
- Ninety-five percent confidence intervals should be used whenever possible.
- Use of the word “correlation” requires reporting of the correlation coefficient.
- References should be numbered sequentially in the order they are cited in the text.
- All references listed must be cited within the text.
- List references double-spaced in a separate reference section immediately following the text. All references should be in the style described in the American Medical Association Manual of Style. Note the following examples:
- Journal : Qadeer, MA, Richter, JE, Brotman, DJ, Hospital-acquired gastrointestinal bleeding outside the critical care unit. J Hosp Med. 2006; 1:13-20.
- Book (entire) : Sherlock S, Dooley J. Diseases of the Liver and Biliary System. 9th ed. Oxford, England: Blackwell Scientific Publications; 1993.
- Book (chapter) : Cole BR. Cystinosis and cystinuria. In: Jacobson HR, Striker GE, Klahr S, eds. The Principles and Practice of Nephrology. Philadelphia, Pa: BC Decker Inc; 1991:396-403.
- Web site : Health Care Financing Administration. 1996 statistics at a glance. Available at: http://www.hcfa.gov/stats/stathili.htm. Accessed December 2, 1996.
- List all authors when there are six or fewer; for seven or more, list only the first three and add “et al.”
- Use Index Medicus abbreviations for journal names.
- Include references to unpublished material in the text parenthetically, not in the references (e.g., papers in preparation or submitted for publication, papers presented orally at a meeting, personal communication), and submit a letter of permission from the cited persons to cite such communications. In general, avoid citations to unpublished scientific research.
Standards for Systematic reviews, Meta-analyses, Clinical Trials, and studies of diagnostic tests:
Authors of systematic reviews and meta-analyses of randomized controlled trials should consult the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) Statement for guidance on content that should be included in the report.
Authors of systematic reviews and meta-analyses of observational studies in epidemiology should similarly consult the MOOSE (Meta-analysis of observational studies in epidemiology) Statement for reporting requirements.
Authors reporting the results of randomized, controlled clinical trials should refer to the CONSORT statement while preparing their manuscript for submission. This statement includes a checklist (for reviewers) and flow diagram (for publication) detailing the methods used by the authors (www.consort-statement.org).
Manuscripts addressing the evaluation of diagnostic tests should conform to the recommendations of the STARD initiative ( www.consort-statement.org/stardstatement.htm).
Clinical Trials Registration:
We highly recommend that researchers register clinical trials, particularly large randomized trials, in a public registry. A clinical trial is any study that prospectively assigns human participants to intervention and comparison groups to investigate the cause-and-effect relationship between a medical intervention and a health outcome. Authors can obtain current information on acceptable registries at http://www.icmje.org .
Authors’ Professional and Ethical Responsibilities
The Journal of Hospital Medicine adheres to the guidelines set by the International Committee of Medical Journals Editors regarding authorship ( www.icmje.org ).
- Persons designated as authors must meet all of the following criteria:
- Contributing to the conception and design, or analyzing and interpreting data.
- Drafting the article or revising it critically for important intellectual content.
- Approving the final version to be published. Supporting the study or collecting data does not constitute authorship. Authorship based solely on position (e.g., research supervisor, department head) is not permitted.
JHM adheres to the authorship guidelines set by the International Committee of Medical Journal Editors (www.icmje.org). If you are invited to submit a revised manuscript for possible publication, you will be asked to submit a form detailing the contributions of each author. The form, which must be uploaded as Supplementary Material Not for Review, will appear online as Supporting Information if the article is published. Failure to upload the form with your revision will block further manuscript processing.
Conflict of Interest:
The Journal of Hospital Medicine complies with the position of the International Committee of Medical Journal Editors on “Conflict of Interest.” Conflict of interest for authors is defined as “financial and other conflicts of interest that might bias their work” ( www.icmje.org ).
Authors are responsible for making certain that their manuscript provides full disclosure of all potential conflicts of interest (financial or non-financial) and any other pertinent final information. If any of the authors or their institution received commercial support for the submitted work (e.g., payment, grant, or assistance with study design, analysis, or manuscript preparation, it must be included on the manuscript's title page.
When a revision is requested of authors, the ICMJE Conflict of Interest form will be sent to all authors, who must complete the form and return it to the corresponding author, who will transpose all relevant disclosures to the revision so they appear on the title page.
All authors must disclose if they, or any immediate family member, within the last three years have had any affiliations that they consider to be relevant and important with any organization that to any author’s knowledge has a direct interest, particularly a financial interest, in the subject matter or materials discussed. Such affiliations include, but are not limited to: employment by an industrial concern, ownership of stock, membership on a standing committee or board of directors, consultancies, or being publicly associated with a company or its products.
Other areas of real or perceived conflict of interest include the receipt of honoraria, consulting fees, grants, or funds from such corporations or individuals representing such corporations. Conflict of interest can exist whether or not an individual believes that the relationship affects his or her scientific judgment.
JHM is a journal of the Society of Hospital Medicine, which also has policies about conflict of interest and its relationship with industry partners. To learn more about SHM's relationship with industry partners visit http://www.hospitalmedicine.org/Content/NavigationMenu/AboutSHM/Industry...
Ethical Conduct of Research:
Research that involves human participants includes investigations that use only human blood, tissue, or medical records. The authors must confirm review of the study by the appropriate institutional review board (IRB) or affirm that the protocol is consistent with the principles of the Declaration of Helsinki (World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA 1997;277:925-6.) If the authors did not obtain IRB approval before the start of the study, they should so state and explain the circumstances. If the study was exempt from review, the authors must state that such exemption complied with the policy of their local IRB. They should affirm that study participants gave their informed consent or state that an IRB approved conduct of the research without explicit consent from the participants. If patients are identifiable from illustrations, photographs, pedigrees, case reports, or other study data, the authors must submit the release form for each such individual (or copies of the figures with the appropriate release statement) giving permission for publication with the manuscript.
Scientific Misconduct and Breach of Publication Ethics:
Breaches of publication ethics include: failure to reveal financial conflicts of interest; redundant or duplicate publications; omitting a deserving author or adding a non-contributing author; misrepresenting publication status in the bibliography (erroneously claiming that a paper is “in press”, fabrication, falsification, and plagiarism with intent to deceive by the authors. Honest errors or differences in interpretation are not considered misconduct.
If research misconduct is suspected, the Editor reserves the right to notify and forward the submitted manuscript to the chief executive officer or dean of the sponsoring institution, the funding institution, or other appropriate authority for investigation. The Editor will notify the authors of the journal’s intention to report a suspicion of research misconduct.
Statements of Disclosure: If needed, please include statements of disclosure for the following: Statement by the responsible author certifying that all coauthors have seen and agree with the contents of the manuscript; author’s statement of responsibility for clinical trial data (if applicable); statement certifying that the submission (aside from abstracts) is not under review by any other publication; and/or disclosure of any financial interest or notification of redundant or duplicate publication; disclosures of financial support from, or equity positions in, manufacturers of drugs or products mentioned in the manuscript; and trial registry information.
Open access content is immediately and permanently available online and allows users to link, read, download, store, use, and data-mine the content of that article, even commercially, without permission—provided that credit is given to the original authors and journal.
All accepted open access articles receive the following open access benefits:
- Articles will be published under the CC-BY license
- The author will retain the copyright of the article
- The article will be freely available in perpetuity on the journal website for any user, worldwide
- The article will have the OPEN indicator published on the article in the PDF and online to make it visible to readers that the article is open access
- B) The final version of the article will be submitted to PubMed Central as open access, and sent to the corresponding author for final approval. Once the corresponding author approves, the article will be published in PubMedCentral.
- C) (ORIGINAL LANGUAGE: The final version of article will be submitted to PubMed Central as open access on the authors’ behalf.)
All open access articles are subject to peer review, editorial oversight, and the journal’s production process. The submission and review process for open access articles will follow the same process as for non-open access articles, but there are additional forms and steps that need to be taken in order to publish your work as open access.
Authors have up to one year to request that their article be published as open access.
Author requirements: An Article Process Charge (APC) of $4,000 is payable to the publisher in order to publish open access on this site, and completion of licensing and payment forms. . If you wish to request Open Access, email JHospitalmedicine@frontlinemedcom.com, and within 2 weeks of the request, the publisher will email you the invoice.
Editorial Office Contact Information
Journal of Hospital Medicine